oca cell lines es2 (ATCC)
Structured Review

Oca Cell Lines Es2, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1236 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es2+cell+lines/ES-2/pmc12909132-36-1-18
Average 97 stars, based on 1236 article reviews
Images
1) Product Images from "Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer"
Article Title: Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer
Journal: Oncogene
doi: 10.1038/s41388-026-03689-w
Figure Legend Snippet: A Structures of selected ERX-41 analogs. B Heatmap depicting the antiproliferative effects of selected ERX analogs on OCa cells in vitro. C MTT assay results demonstrating the potency of ERX-208 over ERX-41 on the viability of OCa cells in vitro. D – F MTT assay results showing the impact of ERX-208 on the viability of OCa cells in vitro. G , H , Colony formation assay results illustrating the effect of ERX-208 on the clonogenic potential of OCa cells in vitro. The left panel ( G ) presents representative images of colonies formed, while the right panel ( H ) quantifies the number of colonies in control versus ERX-208-treated cells. I ERX-208 induces caspase-dependent apoptosis in treated ES2 OCa cells. Caspase 3/7 activity (fold change) was measured after treatment with ERX-208 (500 nM) alone or in combination with Q-VD-Oph (caspase inhibitor), ferrostatin-1 (ferroptosis inhibitor), or necrostatin-1 (necroptosis inhibitor). Data are represented as mean ± SEM. ns not significant; *** p < 0.001; **** p < 0.0001.
Techniques Used: In Vitro, MTT Assay, Colony Assay, Control, Activity Assay
Figure Legend Snippet: A Time-course analysis of ERX-208 (1 μM) treatment on mRNA expression of ER stress-related genes, sXBP1 and CHOP, in SKOV3, OVCAR3, ES2, and OVCAR4 cells. B RT-PCR analysis showing the temporal effects of ERX-208 (1 μM) on the expression of XBP1 (unspliced XBP1 (XBP1u) and spliced XBP1 (XBP1s)) in OCa39, OVCAR8, OVCAR3, and ES2 cells. C Western blot analysis of UPR component activation in OCa39 and OVCAR8 OCa cell lines treated with ERX-208 for the indicated time points. D Transmission electron microscopy of OVCAR8 cells illustrating the effects of vehicle and ERX-208 treatments on subcellular structures after 16 h.; yellow arrows indicate the ER. Scale bar represents 100 nm.
Techniques Used: Expressing, Reverse Transcription Polymerase Chain Reaction, Western Blot, Activation Assay, Transmission Assay, Electron Microscopy
Figure Legend Snippet: A Representative IHC images of tissue sections from PDE models treated with ERX-208 (1 µM), stained for Ki67, a proliferation marker. B Quantification of Ki67 staining in PDE models. Quantitative data are presented as mean ± SEM. C , D Invasion assay results illustrating the impact of ERX-208 on OCa ascites model cells. The left panel ( C ) presents representative images of invaded cells, while the right panel ( D ) quantifies the number of invaded cells following treatment with ERX-208. E – G Effects of ERX-208 on ES2 xenograft tumor models treated with a single dose of 10 mg/kg i.p. E Tumor volume measurements of mice treated with vehicle or ERX-208. F Tumor weights at the endpoint of the study. G Quantification of the number of tumor nodules in treated and vehicle groups. Data are represented as mean ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
Techniques Used: Staining, Marker, Invasion Assay
Related Articles
other:Article Title: Role of KLF5 in enhancing ovarian cancer stemness and PARPi resistance: mechanisms and therapeutic targeting. Article Snippet: Article Title: Paclitaxel-resistance facilitates glycolytic metabolism via Hexokinase-2-regulated ABC and SLC transporter genes in ovarian clear cell carcinoma. Article Snippet: Ovarian clear cell carcinoma (OCCC) frequently develops resistance to platinum-based therapies, which is regarded as an aggressive subtype.. However, metabolic changes in paclitaxel resistance remain unclear.. Herein, we present the metabolic alternations of paclitaxel resistance in bioenergetic profiling in OCCC. Article Title: SLFN11 is a <i>BRCA</i> Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma Article Snippet: SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-GradeSerousOvarianCancer andClearCell Ovarian Carcinoma Hidehiko Akashi, Nozomi Yachida, Haruka Ueda, Manako Yamaguchi, Kaoru Yamawaki, Ryo Tamura, Kazuaki Suda, Tatsuya Ishiguro, Sosuke Adachi, Yoshikazu Nagase, Yutaka Ueda, Masashi Ueda, KaoruAbiko, Masahiro Kagabu, Tsukasa Baba, HirofumiNakaoka, Takayuki Enomoto, JunkoMurai, and Kosuke Yoshihara Article Title: Role of KLF5 in enhancing ovarian cancer stemness and PARPi resistance: mechanisms and therapeutic targeting Article Snippet: Article Title: Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approaches Article Snippet: Article Title: Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approaches. Article Snippet: Expressing:Article Title: The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma Article Snippet: .. The Article Title: The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma. Article Snippet: .. The |
